Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Piramal Pharma Ltd.
NSE: PPLPHARMA
|
BSE: 543635
|
ISIN: INE0DK501011
|
Industry: Pharmaceuticals
|
Momentum Trap
171.6600
-0.27
(
-0.16
%)
NSE
Jul 15, 2026
15:58 PM
29.75% Gain from 52W Low
Volume:
2.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Piramal Pharma Ltd.
30 Jan 2025
171.66
-0.16%
Piramal Pharma | Q3FY25 Result Update
Buy:
Piramal Pharma Ltd.
by
Edelweiss
Target: 283
Target
Edelweiss
CDMO business to drive growth
Piramal Pharma Ltd. has an
average target
of 225.00 from 3 brokers.
More from Piramal Pharma Ltd.
Recommended
Market closes flat amid rising tensions in the Strait of Hormuz
Trendlyne Marketwatch |
15 Jul 2026, 03:28PM
Five stocks to buy from analysts this week - July 14, 2026
The Baseline |
14 Jul 2026, 04:56PM
IPO market buzz continues with SBI Funds launching a Rs 9,813 crore issue
|
13 Jul 2026, 06:17PM